Global Drug Screening Market is estimated at $4.8 Bn (2020) growing at a CAGR of 15.8% through 2020-2025. The market growth is driven by growing drug use after COVID-19 pandemic and increase in abuse ...

Cepheid today announced that Health Canada has issued Cepheid a medical device licence for Xpert® HIV-1 Viral Load XC, a next-generation extended-coverage (XC) test intended to aid in assessing HIV ...

HepQuant, LLC, a leader in developing noninvasive, blood-based, quantitative testing to assess liver health, is proud to announce ISO 13485 certification as its latest milestone in operational ...

Bloodstream infections caused by yeast rose by 4% in 2024, compared to 2023. Latest data from UK Health Security Agency ...

The overturning of the FDA’s lab-developed tests rule is just the tip of the iceberg. With the loss of Chevron deference, ...

An 'AI scientist', working in collaboration with human scientists, has found that combinations of cheap and safe drugs - used to treat conditions such ...

Denali Therapeutics' experimental drug for amyotrophic lateral sclerosis ... including a look at pre-specified subgroups, longer-term clinical effects, and effects on ALS biomarkers, including ...

A dual-target CAR T cell therapy approach shows promise for slowing tumor growth in a notoriously aggressive and fast-growing ...

A Helena probationer is jailed on a felony charge for trying to use someone else's urine for a drug test. Jessica Mae McNees faces a charge of tampering with or fabricating evidence.

Background Pulmonary hypertension (PH) is a progressive cardiopulmonary condition associated with increased morbidity and ...

More than three decades ago, the U.S. Food and Drug Administration (FDA) approved Bacillus Calmette-Guérin (BCG) as the first ...

He held leadership roles in drug discovery, clinical development, safety, and medical affairs. He is now VP medicine development lead for a liver programme in GSK’s Respiratory, Immunology and ...